Abstract:Efforts to develop new drug-based therapeutic approaches against Intestinal Bowel Disease (IBD) must overcome several challenges, including issues of delivery, potential off-target effects, safety, toxicity, large-scale production costs and tissue specificity. We and other groups have recently demonstrated that artificially synthesized nanoparticles may be used to specifically deliver low doses of drugs (e.g., siRNAs, proteins and peptides) to certain cell types or tissues. However, the synthetic nanoparticles have, to date, 2 major limitations: (1) the potential toxicity of each of their constituent that has to be tested prior to clinical application; and (2) their limited production scale. The use, for IBD treatment, of nanoparticles derived from natural sources may overcome these limitations. Ginger, which contains many anti-inflammatory compounds, has been used as traditional medicine for centuries. Here, we isolated natural nanoparticles from ginger, tested their efficacy for targeting the colon and assessed their intrinsic anti-inflammatory potential using the well-established model of Dextran Sulfate Sodium (DSS) induced-colitis. The size distribution of ginger derived nanoparticles (GDNPs) was determined using multiple approaches: photon correlation spectroscopy (PCS), Atomic Force Microscopy (AFM) and scattering electron microscopy (EM). The average size of GDNPs was ∼220 nm. Interestingly, we demonstrated that the retention of orally administered GDNPs in the colon was higher in non-starved mice than in starved mice, suggesting a natural and efficient way of administering GDNPs. We observed that DSS-induced acute inflammation was attenuated by a specific population (GDNPs 2) as reflected by a reduced spleen weight, an increased colon length, a reduced MPO level and histological examination. We also showed that GDNPs 2 reduced the expression of pro-inflammatory cytokines, such as TNF-α, IL6 and IL-1β, and increased the expression of anti-inflammatory cytokines, including IL-10 and IL-22, demonstrating that GDNPs 2 blocked some factors that damage the intestines (TNF-α, IL-6 and IL-1β) while promoting factors that heal the intestines (IL-10 and IL-22). We anticipate that this study will represent a proof of principle for a novel natural, nontoxic delivery system that targets the inflamed intestinal mucosa, blocks damaging factors while promoting healing factors and may easily be developed for large-scale production aimed at the treatment of IBD.

Payload‐free protein nanoparticles target inflamed colons to restore intestinal barrier integrity for effectively treating inflammatory bowel diseases

Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model

ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease

PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS

Targeted V-type peptide-decorated nanoparticles prevent colitis by inhibiting endosomal TLR signaling and modulating intestinal macrophage polarization

P-139 YI Ginger Derived Nanoparticles

pH-responsive CuS/DSF/EL/PVP nanoplatform alleviates inflammatory bowel disease in mice via regulating gut immunity and microbiota

Crgd Peptide Incorporated with Patchouli Alcohol Loaded Silk Fibroin Nanoparticles for Enhanced Targeting of Inflammatory Sites in Colitis.

Ginseng-derived nanoparticles alleviate inflammatory bowel disease via the TLR4/MAPK and p62/Nrf2/Keap1 pathways

Versatile Inulin/trans-Ferulic Acid/silk Sericin Nanoparticles-Nourished Probiotic Complex with Prolonged Intestinal Retention for Synergistic Therapy of Inflammatory Bowel Disease

pH-Sensitive Nanoparticles for Colonic Delivery Anti-miR-301a in Mouse Models of Inflammatory Bowel Diseases

"Two-birds-one-stone" colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis

Reactive Oxygen Species‐Activated CO Versatile Nanomedicine with Innate Gut Immune and Microbiome Remodeling Effects for Treating Inflammatory Bowel Disease

Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery

Readily Available Oral Prebiotic Protein Reactive Oxygen Species Nanoscavengers for Synergistic Therapy of Inflammation and Fibrosis in Inflammatory Bowel Disease

Microfluidics-Derived Microparticles with Prebiotics and Probiotics for Enhanced in Situ Colonization and Immunoregulation of Colitis.

A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota

Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment

CCL4-mediated Targeting of Spleen Tyrosine Kinase (syk) Inhibitor Using Nanoparticles Alleviates Inflammatory Bowel Disease

Medicinal plant-based drug delivery system for inflammatory bowel disease

All-in-one theranostic nano-platform based on polymer nanoparticles for BRET/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis